Multicell Immunotherapeutics, Inc. v. GT Biopharma, Inc., and its predecessors Oxis International, Inc. and Oxis Biotech, Inc.
| Multicell Immunotherapeutics, Inc. |
| GT Biopharma, Inc., and its predecessors Oxis International, Inc. and Oxis Biotech, Inc. |
| 4:2017cv06491 |
| November 8, 2017 |
| US District Court for the Northern District of California |
| Elizabeth D Laporte |
| Jeffrey S White |
| Other Statutes: Arbitration |
| 09 U.S.C. ยง 1 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on March 7, 2018. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 16
ORDER by Judge Jeffrey S. White granting as unopposed #12 Motion to Dismiss for Lack of Jurisdiction. (jjoS, COURT STAFF) (Filed on 3/7/2018)
|
| Filing 15 NOTICE of Voluntary Dismissal and [Proposed] Order by Multicell Immunotherapeutics, Inc. (Greenbaum, Martin) (Filed on 3/5/2018) Modified on 3/6/2018 (cjlS, COURT STAFF). |
| Filing 14 Statement of Non-Opposition re #12 MOTION to Dismiss for Lack of Jurisdiction, #13 Order filed by Multicell Immunotherapeutics, Inc. (Related document(s) #12 , #13 ) (Greenbaum, Martin) (Filed on 3/5/2018) Modified on 3/6/2018 (cjlS, COURT STAFF). |
|
Filing 13
ORDER SETTING HEARING as to #12 MOTION to Dismiss for Lack of Jurisdiction . Signed by Judge Jeffrey S. White on 2/20/18. Responses due by 3/5/2018. Replies due by 3/12/2018. Motion Hearing set for 4/13/2018 09:00 AM in Oakland, Courtroom 5, 2nd Floor before Judge Jeffrey S. White. (jjoS, COURT STAFF) (Filed on 2/20/2018) Modified on 2/20/2018 (jjoS, COURT STAFF).
|
| Filing 12 MOTION to Dismiss for Lack of Jurisdiction filed by GT Biopharma, Inc., and its predecessors Oxis International, Inc. and Oxis Biotech, Inc.. Responses due by 3/5/2018. Replies due by 3/12/2018. (Rudd, Amy) (Filed on 2/19/2018) |
|
Filing 11
ORDER VACATING CASE MANAGEMENT. Signed by Judge Jeffrey S. White on 2/12/18. (jjoS, COURT STAFF) (Filed on 2/12/2018)
|
| Electronic filing error. Incorrect event used. [err101] This filing will not be processed by the clerks office. Please re-file in its entirety ONLY Re: [10-1] Petitioner's Certification of Interested Entities and [10-2] Respondent's Certification of Interested Entities filed by GT Biopharma, Inc., and its predecessors Oxis International, Inc. and Oxis Biotech, Inc., Multicell Immunotherapeutics, Inc. (cjlS, COURT STAFF) (Filed on 2/9/2018) |
| Filing 10 JOINT CASE MANAGEMENT STATEMENT filed by Multicell Immunotherapeutics, Inc., GT Biopharma, Inc. (Attachments: #1 Declaration Petitioner's Certification of Interested Entities and Persons, #2 Declaration Defendant's Certification of Interested Entities or Persons)(Greenbaum, Martin) (Filed on 2/8/2018) Modified on 2/9/2018 (cjlS, COURT STAFF). |
| Filing 9 NOTICE of Appearance by Amy Lynne Rudd (Rudd, Amy) (Filed on 1/24/2018) |
| Filing 8 CERTIFICATE OF SERVICE by Multicell Immunotherapeutics, Inc. (Greenbaum, Martin) (Filed on 1/5/2018) |
|
Filing 7
ORDER SETTING CASE MANAGEMENT CONFERENCE AND REQUIRING JOINT CASE MANAGEMENT CONFERENCE STATEMENT. Signed by Judge Jeffrey S. White on 11/21/17. Joint Case Management Statement due by 2/9/2018. Initial Case Management Conference set for 2/16/2018 11:00 AM in Courtroom 5, 2nd Floor, Oakland. (jjoS, COURT STAFF) (Filed on 11/21/2017)
|
|
Filing 6
ORDER, Case reassigned to Judge Jeffrey S. White. Magistrate Judge Elizabeth D. Laporte no longer assigned to the case. This case is assigned to a judge who participates in the Cameras in the Courtroom Pilot Project. See General Order 65 and http://cand.uscourts.gov/cameras. Signed by Executive Committee on 11/20/17. (Attachments: #1 Notice of Eligibility for Video Recording)(haS, COURT STAFF) (Filed on 11/20/2017)
|
| Filing 5 CLERK'S NOTICE OF IMPENDING REASSIGNMENT TO A U.S. DISTRICT COURT JUDGE: The Clerk of this Court will now randomly reassign this case to a District Judge because a party has not consented to the jurisdiction of a Magistrate Judge. You will be informed by separate notice of the district judge to whom this case is reassigned. ALL HEARING DATES PRESENTLY SCHEDULED BEFORE THE CURRENT MAGISTRATE JUDGE ARE VACATED AND SHOULD BE RE-NOTICED FOR HEARING BEFORE THE JUDGE TO WHOM THIS CASE IS REASSIGNED. This is a text only docket entry; there is no document associated with this notice. (shyS, COURT STAFF) (Filed on 11/17/2017) |
| Filing 4 CONSENT/DECLINATION to Proceed Before a US Magistrate Judge by Multicell Immunotherapeutics, Inc... (Greenbaum, Martin) (Filed on 11/16/2017) |
|
Filing 3
Initial Case Management Scheduling Order with ADR Deadlines: Case Management Statement due by 1/30/2018. Initial Case Management Conference set for 2/6/2018 10:00 AM. Signed by Magistrate Judge Elizabeth D. Laporte on 11/08/17. (aaaS, COURT STAFF) (Filed on 11/8/2017)
|
| Filing 2 Case assigned to Magistrate Judge Elizabeth D. Laporte. Counsel for plaintiff or the removing party is responsible for serving the Complaint or Notice of Removal, Summons and the assigned judge's standing orders and all other new case documents upon the opposing parties. For information, visit E-Filing A New Civil Case at http://cand.uscourts.gov/ecf/caseopening.Standing orders can be downloaded from the court's web page at www.cand.uscourts.gov/judges. Upon receipt, the summons will be issued and returned electronically. Counsel is required to send chambers a copy of the initiating documents pursuant to L.R. 5-1(e)(7). A scheduling order will be sent by Notice of Electronic Filing (NEF) within two business days. Consent/Declination due by 11/22/2017. (jmlS, COURT STAFF) (Filed on 11/8/2017) |
| Filing 1 PETITION TO CONFIRM ARBITRATION AWARD; (NO PROCESS); against GT Biopharma, Inc., and its predecessors Oxis International, Inc. and Oxis Biotech, Inc. (Filing fee $400 receipt number 0971-11863001). Filed by Multicell Immunotherapeutics, Inc.. (Attachments: #1 Civil Cover Sheet)(Greenbaum, Martin) (Filed on 11/8/2017) Modified on 11/9/2017 (aaaS, COURT STAFF). |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the California Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
| Search for this case: Multicell Immunotherapeutics, Inc. v. GT Biopharma, Inc., and its predecessors Oxis International, Inc. and Oxis Biotech, Inc. | |
|---|---|
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Web | [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ] |
| Respondent: GT Biopharma, Inc., and its predecessors Oxis International, Inc. and Oxis Biotech, Inc. | |
| Represented By: | Amy Lynne Rudd |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
| Petitioner: Multicell Immunotherapeutics, Inc. | |
| Represented By: | Martin G. Greenbaum |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
